Zai Lab Limited ADR (NASDAQ: ZLAB) open the trading on Wednesday, with great promise as it jumped 0.42% to $28.94, before settling in for the price of $28.82 at the close. Taking a more long-term approach, ZLAB posted a 52-week range of $13.48-$31.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 2095.12%. Meanwhile, its Annual Earning per share during the time was -16.93%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 13.45%. This publicly-traded company’s shares outstanding now amounts to $99.12 million, simultaneously with a float of $98.53 million. The organization now has a market capitalization sitting at $2.87 billion. At the time of writing, stock’s 50-day Moving Average stood at $21.94, while the 200-day Moving Average is $19.56.
Zai Lab Limited ADR (ZLAB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Zai Lab Limited ADR’s current insider ownership accounts for 0.59%, in contrast to 42.65% institutional ownership. According to the most recent insider trade that took place on Oct 02 ’24, this organization’s Chief Financial Officer sold 301 shares at the rate of 25.40, making the entire transaction reach 7,645 in total value, affecting insider ownership by 15,161.
Zai Lab Limited ADR (ZLAB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.8 per share during the current fiscal year.
Zai Lab Limited ADR’s EPS increase for this current 12-month fiscal period is 13.45% and is forecasted to reach -1.77 in the upcoming year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Let’s observe the current performance indicators for Zai Lab Limited ADR (ZLAB). It’s Quick Ratio in the last reported quarter now stands at 3.29. The Stock has managed to achieve an average true range (ATR) of 1.29. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.89.
In the same vein, ZLAB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.07, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -1.77 at the market close of one year from today.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
[Zai Lab Limited ADR, ZLAB] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 90.06% While, its Average True Range was 1.32.
Raw Stochastic average of Zai Lab Limited ADR (ZLAB) in the period of the previous 100 days is set at 95.14%, which indicates a major rise in contrast to 88.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 49.02% that was lower than 49.40% volatility it exhibited in the past 100-days period.
